Aguettant will be showcasing our brand-new pain product, Dzuveo. Dzuveo is a sublingual sufentanil 30mcg tablet which is indicated for acute moderate to severe pain in adults. For anyone wanting to find out more, visit www.dzuveo.co.uk. For Dzuveo prescribing information, click here: https://www.emcpi.com/pi/42044

Adverse events should be reported. Reporting forms and information can be found at http://yellowcard.mhra.gov.uk/. Adverse events should also be reported to Aguettant Limited on +44 1275 463 691.

AGUK-328-09/2023